Kimberly-Clark and Kenvue shareholders have overwhelmingly approved the proposed acquisition of Kenvue. The vote clears a key procedural step toward combining the two businesses into a single health ...

Near a 12-year low, Kimberly-Clark may be one of the best deep value stocks for income investors to buy in 2026.

Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company.Kenvue shareholders will receive $3.50 per share in ...

Why the Kimberly-Clark Price Target Just Changed Kimberly-Clark has just seen its price target updated, and that shift is rooted in a fresh look at the story investors are telling themselves about ...

Kimberly-Clark announced Monday it's struck an agreement to buy Kenvue in a deal valued at $48.7 billion. The combined company would bring together brands like Huggies and Kleenex with the likes of ...

Kimberly-Clark will buy Kenvue for $48.7 billion. A merged Kimberly-Clark-Kenvue could have $32 billion in annual sales and profits as high as $5.5 billion. At Kimberly-Clark's current $40 billion ...